{"data":[{"accessionNo":"0002012383-26-003813","formType":"SCHEDULE 13G/A","amendmentNo":8,"issuerCik":"0001422143","issuerName":"Kura Oncology Inc","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":7908832,"percentOfClass":8.9,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000919574-26-005536","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Montanova Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":8575422,"percentOfClass":9.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000919574-26-005536","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Aaron Cowen","reportingCik":null,"personType":"HC","sharesOwned":8575422,"percentOfClass":9.7,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000919574-26-005536","formType":"SCHEDULE 13G/A","amendmentNo":6,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-06-30","reportingPerson":"Averill Master Fund, Ltd.","reportingCik":null,"personType":"CO","sharesOwned":7805540,"percentOfClass":8.8,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0001172661-26-002164","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001422143","issuerName":"KURA ONCOLOGY, INC.","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":3736000,"percentOfClass":4.23,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0001172661-26-002164","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001422143","issuerName":"KURA ONCOLOGY, INC.","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-03-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":3736000,"percentOfClass":4.23,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0002100119-26-000682","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001422143","issuerName":"Kura Oncology Inc","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":4428812,"percentOfClass":5.01,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000102909-26-001712","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001422143","issuerName":"Kura Oncology Inc","ticker":"KURA","cusip":"50127T109","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0001172661-26-001243","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4936000,"percentOfClass":5.67,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0001172661-26-001243","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-12-31","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":4936000,"percentOfClass":5.67,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000093751-26-000062","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001422143","issuerName":"KURA ONCOLOGY INC","ticker":"KURA","cusip":null,"securityClass":"COMMON STOCK","eventDate":"2025-12-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":4931090,"percentOfClass":5.7,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"LAMPERT MARK N","reportingCik":null,"personType":"IN","sharesOwned":8677018,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF PARTNERS L P/IL","reportingCik":null,"personType":"IA,PN","sharesOwned":8677018,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF INC/IL","reportingCik":null,"personType":"CO","sharesOwned":8677018,"percentOfClass":9.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF GP HOLDINGS LLC","reportingCik":null,"personType":"OO","sharesOwned":8056651,"percentOfClass":9.3,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0001172661-25-005180","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":4672000,"percentOfClass":5.37,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0001172661-25-005180","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":4672000,"percentOfClass":5.37,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF I GP LLC","reportingCik":null,"personType":"OO","sharesOwned":4416545,"percentOfClass":5.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND L P","reportingCik":null,"personType":"PN","sharesOwned":4416545,"percentOfClass":5.1,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF II GP LLC","reportingCik":null,"personType":"OO","sharesOwned":3640106,"percentOfClass":4.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BIOTECHNOLOGY VALUE FUND II LP","reportingCik":null,"personType":"PN","sharesOwned":3640106,"percentOfClass":4.2,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Biotechnology Value Trading Fund OS LP","reportingCik":null,"personType":"PN","sharesOwned":446606,"percentOfClass":0.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"},{"accessionNo":"0000921895-25-003106","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001422143","issuerName":"Kura Oncology, Inc.","ticker":"KURA","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"BVF Partners OS Ltd.","reportingCik":null,"personType":"CO","sharesOwned":446606,"percentOfClass":0.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/kura"}],"updatedAt":"2026-11-04T09:03:19.314Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/kura","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}